Breast cancer (BC) is a prevalent malignancy. There exists a strong association between gut microbiota (GM) and the development of BC. The GM composition in individuals with BC significantly differs from that in their healthy counterparts. Furthermore, the distribution of GM varies significantly among individuals with different types of BC. The GM can impact BC through metabolite secretion, the gut-mammary axis, and other pathways. Modulating the GM can serve as a very promising potential therapeutic strategy in the treatment of BC. This article will summarize existing research, focusing on the relationship between intestinal microbiota and BC. At the same time, the project will also analyze the application value of intestinal microorganisms in BC intervention work, so as to provide a reference for the further development of BC prevention and treatment work.
基金：
Baoding City Science and Technology and Intellectual Property Bureau (2241ZF339 to YR). [2241ZF339]; Baoding City Science and Technology and Intellectual Property Bureau
第一作者机构：[1]Hebei Univ, Affiliated Hosp, Baoding, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Liu Kuan,Jia Nan,Shi Hongyun,et al.Current and future research on the association between gut microbiota and breast cancer[J].FRONTIERS IN MICROBIOLOGY.2023,14:doi:10.3389/fmicb.2023.1272275.
APA：
Liu, Kuan,Jia, Nan,Shi, Hongyun&Ran, Yuge.(2023).Current and future research on the association between gut microbiota and breast cancer.FRONTIERS IN MICROBIOLOGY,14,
MLA：
Liu, Kuan,et al."Current and future research on the association between gut microbiota and breast cancer".FRONTIERS IN MICROBIOLOGY 14.(2023)
